Harada, H., Miyawaki, T., Ohde, Y., Chiba, Y., Hayashi, H., Tsutani, Y., Tanaka, K., Matsumoto, K., Oshima, M., Miura, S., Aoki, T., Sato, Y., Aiba, T., Azuma, K., Yamaguchi, M., Yamamoto, N., Kenmotsu, H. (2026). Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer: TRAP-OLIGO study (WJOG11118L).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8571